Fresenius Medical Care — February 22, 2023 Due to continued inflationary pressures, Fresenius is exploring closing underperforming dialysis centers, continuing the rational approach to the duopoly with Davita in the dialysis industry. In terms of potential disposals, we've taken a hard look at the portfolio. And I guess all I would say right now is we're looking at what really is too far removed from the core, and also what maybe isn't performing at the kind of margin level we would expect. So that does include noncore dialysis services assets, as I mentioned, and we're also looking at international service markets where either the reimbursement or profitability or scale is maybe no longer viable for us.
Transcript Notes: March 2023
Transcript Notes: March 2023
Transcript Notes: March 2023
Fresenius Medical Care — February 22, 2023 Due to continued inflationary pressures, Fresenius is exploring closing underperforming dialysis centers, continuing the rational approach to the duopoly with Davita in the dialysis industry. In terms of potential disposals, we've taken a hard look at the portfolio. And I guess all I would say right now is we're looking at what really is too far removed from the core, and also what maybe isn't performing at the kind of margin level we would expect. So that does include noncore dialysis services assets, as I mentioned, and we're also looking at international service markets where either the reimbursement or profitability or scale is maybe no longer viable for us.